Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 454

1.

Lifetime health and economic consequences of obesity.

Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G.

Arch Intern Med. 1999 Oct 11;159(18):2177-83.

PMID:
10527295
2.

Lifetime health and economic benefits of weight loss among obese persons.

Oster G, Thompson D, Edelsberg J, Bird AP, Colditz GA.

Am J Public Health. 1999 Oct;89(10):1536-42.

3.

Economic burden of obesity-related chronic diseases in Mainland China.

Zhao W, Zhai Y, Hu J, Wang J, Yang Z, Kong L, Chen C.

Obes Rev. 2008 Mar;9 Suppl 1:62-7. doi: 10.1111/j.1467-789X.2007.00440.x.

PMID:
18307701
4.

Estimated economic costs of obesity to U.S. business.

Thompson D, Edelsberg J, Kinsey KL, Oster G.

Am J Health Promot. 1998 Nov-Dec;13(2):120-7.

PMID:
10346659
5.

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB.

Arch Intern Med. 2002 Sep 9;162(16):1867-72.

PMID:
12196085
6.

The predicted effects of chronic obesity in middle age on medicare costs and mortality.

Cai L, Lubitz J, Flegal KM, Pamuk ER.

Med Care. 2010 Jun;48(6):510-7. doi: 10.1097/MLR.0b013e3181dbdb20.

PMID:
20473195
7.

The 25-year health care costs of women who remain overweight after 40 years of age.

Gorsky RD, Pamuk E, Williamson DF, Shaffer PA, Koplan JP.

Am J Prev Med. 1996 Sep-Oct;12(5):388-94.

PMID:
8909650
8.

Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Rappange DR, Brouwer WB, Hoogenveen RT, Van Baal PH.

Pharmacoeconomics. 2009;27(12):1031-44. doi: 10.2165/11319900-000000000-00000.

PMID:
19908927
9.

Obesity, weight change and risks for hypertension, diabetes and hypercholesterolemia in Japanese men.

Ishikawa-Takata K, Ohta T, Moritaki K, Gotou T, Inoue S.

Eur J Clin Nutr. 2002 Jul;56(7):601-7.

10.

The cost of obesity in Canada.

Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH.

CMAJ. 1999 Feb 23;160(4):483-8.

11.

Current estimates of the economic cost of obesity in the United States.

Wolf AM, Colditz GA.

Obes Res. 1998 Mar;6(2):97-106. Review.

12.

The clinical and economic burden of obesity in a managed care setting.

Oster G, Edelsberg J, O'Sullivan AK, Thompson D.

Am J Manag Care. 2000 Jun;6(6):681-9.

13.

Undiagnosed obesity: implications for undiagnosed hypertension, diabetes, and hypercholesterolemia.

Diaz VA, Mainous AG 3rd, Koopman RJ, Geesey ME.

Fam Med. 2004 Oct;36(9):639-44.

14.

Medical costs of obese Japanese: a 10-year follow-up study of National Health Insurance in Shiga, Japan.

Nakamura K, Okamura T, Kanda H, Hayakawa T, Okayama A, Ueshima H; Health Promotion Research Committee of the Shiga National Health Insurance Organizations.

Eur J Public Health. 2007 Oct;17(5):424-9. Epub 2007 Jan 5.

PMID:
17209225
15.
16.

Social and economic effects of body weight in the United States.

Wolf AM, Colditz GA.

Am J Clin Nutr. 1996 Mar;63(3 Suppl):466S-469S. Review.

PMID:
8615344
17.

Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.

Shearer AT, Bagust A, Ampudia-Blasco FJ, Martínez-Lage Alvarez B, Pérez Escolano I, París G.

Pharmacoeconomics. 2006;24 Suppl 1:49-59. Review.

PMID:
16800162
18.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
19.
20.

Obesity in adulthood and its consequences for life expectancy: a life-table analysis.

Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group.

Ann Intern Med. 2003 Jan 7;138(1):24-32.

PMID:
12513041

Supplemental Content

Support Center